Header Logo

Connection

Joan Walker to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications Joan Walker has written about Antibodies, Bispecific.
Joan Walker
Connection Strength
0.121
Antibodies, Bispecific
  1. Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study. Int J Gynecol Cancer. 2014 Nov; 24(9):1583-9.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.